Literature DB >> 31493813

Manipulation of renal gene expression using oligonucleotides.

Ronak Lakhia1, Abheepsa Mishra1, Vishal Patel2.   

Abstract

Oligonucleotides are small molecules 8-50 nucleotides in length that bind via Watson-Crick base pairing to enhance or repress the expression of target RNA. The use of oligonucleotides to manipulate gene expression in the kidney could be a valuable tool to further understand kidney pathophysiology and can serve as an important complement to genetic studies. This chapter serves as a primer on the use of oligonucleotides in the kidney. We provide an overview of the various ways that oligonucleotides can manipulate gene expression. In addition, we describe the advancements in the development of oligonucleotides for laboratory and clinical use. Finally, instruction is provided on the design and implementation of oligonucleotides for in vitro and in vivo laboratory studies.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antisense oligonucleotides; Gene expression; MicroRNA; Oligonucleotides; RNA; Therapeutics

Mesh:

Substances:

Year:  2019        PMID: 31493813     DOI: 10.1016/bs.mcb.2019.05.006

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  4 in total

Review 1.  The role of PPARα in autosomal dominant polycystic kidney disease.

Authors:  Ronak Lakhia
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-07       Impact factor: 2.894

Review 2.  Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.

Authors:  Marijn F Stokman; Sophie Saunier; Alexandre Benmerah
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 3.  In vivo and in vitro studies of antisense oligonucleotides - a review.

Authors:  Anna Kilanowska; Sylwia Studzińska
Journal:  RSC Adv       Date:  2020-09-17       Impact factor: 4.036

Review 4.  Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot.

Authors:  Harry Wilton-Clark; Toshifumi Yokota
Journal:  Genes (Basel)       Date:  2022-01-28       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.